N. Simon, F. Castinetti, F. Ouliac, N. Lesavre, T. Brue et al., Pharmacokinetic Evidence for Suboptimal Treatment of Adrenal Insufficiency with Currently Available Hydrocortisone Tablets, Clinical Pharmacokinetics, vol.83, issue.7, pp.455-63, 2010.
DOI : 10.7326/0003-4819-141-10-200411160-00007
URL : https://hal.archives-ouvertes.fr/hal-00625323

M. Forss, G. Batcheller, S. Skrtic, and G. Johannsson, Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey, BMC Endocrine Disorders, vol.95, issue.1, p.8, 2012.
DOI : 10.1210/jc.2010-0917

S. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-wauchope et al., Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.2, pp.364-89, 2016.
DOI : 10.1210/jc.2015-1710

E. Husebye, B. Allolio, W. Arlt, K. Badenhoop, S. Bensing et al., Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency, Journal of Internal Medicine, vol.92, issue.2, pp.104-119, 2014.
DOI : 10.1172/JCI116843

O. Ragnarsson, A. Mattsson, J. Monson, F. Nystrom, H. Akerblad et al., The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients, European Journal of Endocrinology, vol.97, issue.2, pp.571-580, 2014.
DOI : 10.1210/jc.2011-1901

C. Betterle, R. Scarpa, S. Garelli, L. Morlin, F. Lazzarotto et al., Addison's disease: a survey on 633 patients in Padova, European Journal of Endocrinology, vol.499, issue.2, pp.773-84, 2013.
DOI : 10.1016/j.gene.2012.03.032

E. Charmandari, A. Johnston, C. Brook, and P. Hindmarsh, Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Journal of Endocrinology, vol.169, issue.1, pp.65-70, 2001.
DOI : 10.1677/joe.0.1690065

C. Cope and E. Black, The Production Rate of Cortisol in Man, BMJ, vol.1, issue.5078, pp.1020-1024, 1958.
DOI : 10.1136/bmj.1.5078.1020

N. Esteban, T. Loughlin, A. Yergey, J. Zawadzki, J. Booth et al., Daily Cortisol Production Rate in Man Determined by Stable Isotope Dilution/Mass Spectrometry, The Journal of Clinical Endocrinology & Metabolism, vol.72, issue.1, pp.39-45, 1991.
DOI : 10.1210/jcem-72-1-39

D. Metzger, N. Wright, J. Veldhuis, A. Rogol, and J. Kerrigan, Characterization of pulsatile secretion and clearance of plasma cortisol in premature and term neonates using deconvolution analysis, J Clin Endocrinol Metab, vol.77, pp.458-63, 1993.

W. Arlt and B. Allolio, Adrenal insufficiency, The Lancet, vol.361, issue.9372, pp.1881-93, 2003.
DOI : 10.1016/S0140-6736(03)13492-7

P. Mah, R. Jenkins, A. Rostami-hodjegan, J. Newell-price, A. Doane et al., Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency, Clinical Endocrinology, vol.38, issue.3, pp.367-75, 2004.
DOI : 10.1016/S0140-6736(00)04006-X

T. Rosen and B. Bengtsson, Premature mortality due to cardiovascular disease in hypopituitarism, The Lancet, vol.336, issue.8710, pp.285-293, 1990.
DOI : 10.1016/0140-6736(90)91812-O

M. Druce, S. Akker, S. Chew, W. Drake, and A. Grossman, Morbidity in patients on long-term steroid replacement therapy, Clinical Endocrinology, vol.141, issue.4, pp.564-570, 2010.
DOI : 10.1111/j.1365-2265.2009.03656.x

R. Bergthorsdottir, M. Leonsson-zachrisson, A. Oden, and G. Johannsson, Premature Mortality in Patients with Addison???s Disease: A Population-Based Study, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.12, pp.4849-53, 2006.
DOI : 10.1210/jc.2006-0076

T. Zueger, P. Kirchner, C. Herren, S. Fischli, M. Zwahlen et al., Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.10, pp.1938-1980, 2012.
DOI : 10.1210/jc.2012-2432
URL : https://academic.oup.com/jcem/article-pdf/97/10/E1938/10782240/jcem1938.pdf

H. Filipsson, J. Monson, M. Koltowska-haggstrom, A. Mattsson, and G. Johannsson, The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.10, pp.3954-61, 2006.
DOI : 10.1210/jc.2006-0524

S. Peacey, Y. Guo, C. Eastell, R. Weetman, and A. , Optimization of glucocorticoid replacement therapy: the long-term effect on bone mineral density, Clinical Endocrinology, vol.120, issue.6, pp.815-822, 1999.
DOI : 10.7326/0003-4819-120-3-199402010-00005

J. Schulz, K. Frey, M. Cooper, K. Zopf, M. Ventz et al., Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency, European Journal of Endocrinology, vol.75, issue.4, pp.531-539, 2016.
DOI : 10.1111/j.1365-2265.2011.04074.x

L. Behan, G. Kelleher, M. Hannon, J. Brady, R. B. Tormey et al., Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients, European Journal of Endocrinology, vol.80, issue.10, pp.141-50, 2014.
DOI : 10.1210/jc.80.10.2859

B. Bleicken, S. Hahner, M. Loeffler, M. Ventz, O. Decker et al., Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency, Clinical Endocrinology, vol.371, issue.Spec No, pp.297-304, 2010.
DOI : 10.1007/BF03345252

S. Hahner, M. Loeffler, M. Fassnacht, D. Weismann, A. Koschker et al., Impaired Subjective Health Status in 256 Patients with Adrenal Insufficiency on Standard Therapy Based on Cross-Sectional Analysis, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.10, pp.3912-3934, 2007.
DOI : 10.1210/jc.2007-0685

W. Buning, J. Brummelman, P. Koerts, J. Dullaart, R. Van-den-berg et al., The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency ??? Results from a randomized controlled trial, Psychoneuroendocrinology, vol.55, pp.36-47, 2015.
DOI : 10.1016/j.psyneuen.2015.02.001

S. Benson, P. Neumann, N. Unger, M. Schedlowski, K. Mann et al., Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency, European Journal of Endocrinology, vol.96, issue.4, pp.679-85, 2012.
DOI : 10.1210/jc.2010-2490

N. Alonso, M. Granada, A. Lucas, I. Salinas, J. Reverter et al., Evaluation of two replacement regimens in primary adrenal insufficiency patients. Effect on clinical symptoms, health-related quality of life and biochemical parameters, Journal of Endocrinological Investigation, vol.46, issue.Suppl.4, pp.449-54, 2004.
DOI : 10.1046/j.1365-2265.1997.87897.x

A. Qureshi, A. Bahri, L. Breen, S. Barnes, J. Powrie et al., The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol, Clinical Endocrinology, vol.20, issue.5, pp.632-637, 2007.
DOI : 10.1016/0026-0495(88)90164-3

Y. Fujita, T. Kitamura, M. Otsuki, D. Tamada, Y. Tabuchi et al., Exenatide Alters Absorption of Hydrocortisone in a Diabetic Patient With Panhypopituitarism: Iatrogenic Adrenal Insufficiency, Diabetes Care, vol.36, issue.1, p.8, 2013.
DOI : 10.2337/dc12-1499

B. Linder, N. Esteban, A. Yergey, J. Winterer, D. Loriaux et al., Cortisol production rate in childhood and adolescence, The Journal of Pediatrics, vol.117, issue.6, pp.892-898, 1990.
DOI : 10.1016/S0022-3476(05)80128-3

D. Shulman, M. Palmert, S. Kemp, L. Wilkins, D. Therapeutics et al., Adrenal Insufficiency: Still a Cause of Morbidity and Death in Childhood, PEDIATRICS, vol.119, issue.2, pp.484-94, 2007.
DOI : 10.1542/peds.2006-1612

W. Bonfig, S. Pozza, H. Schmidt, P. Pagel, D. Knorr et al., Hydrocortisone Dosing during Puberty in Patients with Classical Congenital Adrenal Hyperplasia: An Evidence-Based Recommendation, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.10, pp.3882-3890, 2009.
DOI : 10.1210/jc.2009-0942

A. So, T. Bernal, M. Pillsbury, K. Yamamoto, and B. Feldman, Glucocorticoid regulation of the circadian clock modulates glucose homeostasis, Proceedings of the National Academy of Sciences, vol.197, issue.1, pp.17582-17589, 2009.
DOI : 10.1677/JOE-07-0606

B. Ekman, M. Bachrach-lindstrom, T. Lindstrom, J. Wahlberg, J. Blomgren et al., A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency, Clinical Endocrinology, vol.161, issue.Suppl 1, pp.18-25, 2012.
DOI : 10.1530/EJE-09-0170

N. Kluger, N. Matikainen, H. Sintonen, A. Ranki, R. Roine et al., Impaired health-related quality of life in Addison's disease - impact of replacement therapy, comorbidities and socio-economic factors, Clinical Endocrinology, vol.95, issue.4, pp.511-519, 2014.
DOI : 10.1210/jc.2009-1711

K. Lovas and E. Husebye, Continuous subcutaneous hydrocortisone infusion in Addison's disease, European Journal of Endocrinology, vol.157, issue.1, pp.109-121, 2007.
DOI : 10.1530/EJE-07-0052

L. Gagliardi, M. Nenke, T. Thynne, V. Der-borch, J. Rankin et al., Continuous Subcutaneous Hydrocortisone Infusion Therapy in Addison's Disease: A Randomized, Placebo-Controlled Clinical Trial, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.11, pp.4149-57, 2014.
DOI : 10.1210/jc.2014-2433

M. Oksnes, S. Bjornsdottir, M. Isaksson, P. Methlie, S. Carlsen et al., Continuous Subcutaneous Hydrocortisone Infusion versus Oral Hydrocortisone Replacement for Treatment of Addison's Disease: A Randomized Clinical Trial, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.5, pp.1665-74, 2014.
DOI : 10.1210/jc.2013-4253

G. Johannsson, R. Bergthorsdottir, A. Nilsson, H. Lennernas, T. Hedner et al., Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study, European Journal of Endocrinology, vol.161, issue.1, pp.119-149, 2009.
DOI : 10.1530/EJE-09-0170

M. Quinkler, M. Nilsen, R. Zopf, K. Ventz, M. Oksnes et al., Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency, European Journal of Endocrinology, vol.339, issue.6, pp.619-645, 2015.
DOI : 10.1097/MAJ.0b013e3181db6b7a

G. Johannsson, A. Nilsson, R. Bergthorsdottir, P. Burman, P. Dahlqvist et al., Improved Cortisol Exposure-Time Profile and Outcome in Patients with Adrenal Insufficiency: A Prospective Randomized Trial of a Novel Hydrocortisone Dual-Release Formulation, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.2, pp.473-81, 2012.
DOI : 10.1210/jc.2011-1926

J. Newell-price, M. Whiteman, A. Rostami-hodjegan, K. Darzy, S. Shalet et al., Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers, Clinical Endocrinology, vol.144, issue.1, pp.130-135, 2008.
DOI : 10.1002/j.1552-4604.1996.tb04206.x

H. Frisch, K. Parth, E. Schober, and W. Swoboda, Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia., Archives of Disease in Childhood, vol.56, issue.3, pp.208-221, 1981.
DOI : 10.1136/adc.56.3.208

G. Tuli, I. Rabbone, S. Einaudi, V. Di-gianni, D. Tessaris et al., Continuous subcutaneous hydrocortisone infusion (CSHI) in a young adolescent with congenital adrenal hyperplasia (CAH), Journal of Pediatric Endocrinology and Metabolism, vol.2, issue.7-8, pp.561-564, 2011.
DOI : 10.1136/adc.85.1.26

P. Hindmarsh, The child with difficult to control Congenital Adrenal Hyperplasia: is there a place for continuous subcutaneous hydrocortisone therapy, Clinical Endocrinology, vol.86, issue.1, pp.15-23, 2014.
DOI : 10.1136/adc.86.4.266

R. Giordano, F. Guaraldi, E. Marinazzo, F. Fumarola, A. Rampino et al., Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison???s disease, Endocrine, vol.77, issue.Suppl 1, pp.360-368, 2016.
DOI : 10.1111/j.1365-2265.2012.04352.x

W. Arlt, C. Rosenthal, S. Hahner, and B. Allolio, Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements, Clinical Endocrinology, vol.5, issue.0, pp.384-393, 2006.
DOI : 10.1111/j.1365-2265.1976.tb03801.x

V. Raverot, C. Richet, Y. Morel, G. Raverot, and F. Borson-chazot, Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys?? Cortisol II assay, Annales d'Endocrinologie, vol.77, issue.5, pp.620-622, 2016.
DOI : 10.1016/j.ando.2016.05.002

G. Kline, J. Buse, and R. Krause, Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay, Clinical Biochemistry, vol.50, issue.9, pp.475-80, 2017.
DOI : 10.1016/j.clinbiochem.2017.02.008

M. Debono, R. Ross, and J. Newell-price, Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy, European Journal of Endocrinology, vol.157, issue.1, pp.719-748, 2009.
DOI : 10.1530/EJE-07-0052

E. Rousseau, M. Joubert, G. Trzepla, J. Parienti, T. Freret et al., Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency, PLOS ONE, vol.97, issue.Suppl 5, p.135975, 2015.
DOI : 10.1371/journal.pone.0135975.s001

F. Ceccato, N. Albiger, G. Reimondo, A. Frigo, S. Ferasin et al., Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency, European Journal of Endocrinology, vol.93, issue.5, pp.769-76, 2012.
DOI : 10.1210/jc.2008-0125

A. Thomson, M. Devers, A. Wallace, D. Grant, K. Campbell et al., Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to Patients with adrenal insufficiency, Clinical Endocrinology, vol.64, issue.6, pp.789-96, 2007.
DOI : 10.1515/CCLM.2004.264

R. Gow, G. Koren, M. Rieder, and S. Van-uum, Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy, Clinical Endocrinology, vol.58, issue.6, pp.687-93, 2011.
DOI : 10.1016/S0379-0738(99)00179-6

J. Romijn, J. Smit, and S. Lamberts, Intrinsic imperfections of endocrine replacement therapy, European Journal of Endocrinology, vol.149, issue.2, pp.91-98, 2003.
DOI : 10.1530/eje.0.1490091

E. Charmandari, D. Matthews, A. Johnston, C. Brook, and P. Hindmarsh, Serum Cortisol and 17-Hydroxyprogesterone Interrelation in Classic 21-Hydroxylase Deficiency: Is Current Replacement Therapy Satisfactory?, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.10, pp.4679-85, 2001.
DOI : 10.1210/jcem.86.10.7972

G. Noppe, Y. De-rijke, J. Koper, E. Van-rossum, and E. Van-den-akker, Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia, Clinical Endocrinology, vol.100, issue.4, pp.522-529, 2016.
DOI : 10.1210/jc.2014-4328

B. Allolio, J. Hoffmann, E. Linton, W. Winkelmann, M. Kusche et al., DIURNAL SALIVARY CORTISOL PATTERNS DURING PREGNANCY AND AFTER DELIVERY: RELATIONSHIP TO PLASMA CORTICOTROPHIN-RELEASING-HORMONE, Clinical Endocrinology, vol.62, issue.2, pp.279-89, 1990.
DOI : 10.1016/0006-291X(83)91192-0

J. Lindsay and L. Nieman, The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment, Endocrine Reviews, vol.26, issue.6, pp.775-99, 2005.
DOI : 10.1210/er.2004-0025

W. Oelkers, S. Diederich, and V. Bahr, Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone, J Clin Endocrinol Metab, vol.75, pp.259-64, 1992.

S. Smith, G. Macgregor, N. Markandu, J. Bayliss, R. Banks et al., EVIDENCE THAT PATIENTS WITH ADDISON'S DISEASE ARE UNDERTREATED WITH FLUDROCORTISONE, The Lancet, vol.323, issue.8367, pp.11-15, 1984.
DOI : 10.1016/S0140-6736(84)90181-8

M. Jadoul, A. Ferrant, D. Plaen, J. Crabbe, and J. , Mineralocorticoids in the management of primary adrenocortical insufficiency, Journal of Endocrinological Investigation, vol.293, issue.2, pp.87-91, 1991.
DOI : 10.1136/bmj.293.6550.808

A. Knowlton and L. Baer, Cardiac failure in Addison's disease, The American Journal of Medicine, vol.74, issue.5, pp.829-865, 1983.
DOI : 10.1016/0002-9343(83)91074-4

A. Grossman, G. Johannsson, M. Quinkler, and P. Zelissen, THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe, European Journal of Endocrinology, vol.45, issue.9608, pp.165-75, 2013.
DOI : 10.1016/S0140-6736(08)60132-4

G. Williams, L. Braley, and R. Underwood, The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man., Journal of Clinical Investigation, vol.58, issue.1, pp.221-230, 1976.
DOI : 10.1172/JCI108453

T. Flad, J. Conway, S. Cunningham, and T. Mckenna, The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency, Clin Endocrinol, vol.45, pp.529-563, 1996.

E. Ehrlich and M. Lindheimer, Effect of administered mineralocorticoids or ACTH in pregnant women, Journal of Clinical Investigation, vol.51, issue.6, pp.1301-1310, 1972.
DOI : 10.1172/JCI106926

M. Lebbe and W. Arlt, What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy?, Clinical Endocrinology, vol.75, issue.4, pp.497-502, 2013.
DOI : 10.1210/jc.75.1.259

P. Methlie, E. Husebye, S. Hustad, E. Lien, and K. Lovas, Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease, European Journal of Endocrinology, vol.54, issue.4, pp.761-770, 2011.
DOI : 10.1016/S0895-4356(00)00314-0

W. Bonfig, F. Roehl, S. Riedl, H. Dorr, M. Bettendorf et al., Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency, American Journal of Hypertension, vol.17, issue.2, pp.266-72, 2016.
DOI : 10.1111/cen.12498

K. Lovas, J. Loge, and E. Husebye, Subjective health status in Norwegian patients with Addison's disease*, Clinical Endocrinology, vol.30, issue.5, pp.581-589, 2002.
DOI : 10.1046/j.1365-2265.1999.00723.x

W. Arlt, F. Callies, J. Van-vlijmen, I. Koehler, M. Reincke et al., Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency, New England Journal of Medicine, vol.341, issue.14, pp.1013-1033, 1999.
DOI : 10.1056/NEJM199909303411401

E. Gurnell, P. Hunt, S. Curran, C. Conway, E. Pullenayegum et al., Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.2, pp.400-409, 2008.
DOI : 10.1210/jc.2007-1134

M. Srinivasan, B. Irving, K. Dhatariya, K. Klaus, S. Hartman et al., Effect of Dehydroepiandrosterone Replacement on Lipoprotein Profile in Hypoadrenal Women, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.3, pp.761-765, 2009.
DOI : 10.1210/jc.2008-1774

G. Johannsson, P. Burman, L. Wiren, B. Engstrom, A. Nilsson et al., Low Dose Dehydroepiandrosterone Affects Behavior in Hypopituitary Androgen-Deficient Women: A Placebo-Controlled Trial, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.5, pp.2046-52, 2002.
DOI : 10.1210/jcem.87.5.8494

A. Alkatib, M. Cosma, M. Elamin, D. Erickson, B. Swiglo et al., A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials of DHEA Treatment Effects on Quality of Life in Women with Adrenal Insufficiency, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.10, pp.3676-81, 2009.
DOI : 10.1210/jc.2009-0672

A. Brooke, L. Kalingag, F. Miraki-moud, C. Camacho-hubner, K. Maher et al., Dehydroepiandrosterone Improves Psychological Well-Being in Male and Female Hypopituitary Patients on Maintenance Growth Hormone Replacement, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.10, pp.3773-3782, 2006.
DOI : 10.1210/jc.2006-0316